p21^WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor α

REFERENCES

• Acevedo, M. L., and W. L. Kraus. 2003. Mediator and p300/CBP-steroid receptor coactivator complexes have distinct roles, but function synergistically, during estrogen receptor alpha-dependent transcription with chromatin templates. Mol. Cell. Biol. 23:335–348.
   PubMed Web of Science ®Google Scholar
• Albanese, C., M. D'Amico, A. T. Reutens, M. Fu, G. Watanabe, R. J. Lee, R. N. Kitsis, B. Henglein, M. Avantaggiati, K. Somasundaram, B. Thimmapaya, and R. G. Pestell. 1999. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J. Biol. Chem. 274:34186–34195.
   PubMed Web of Science ®Google Scholar
• Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
   PubMed Web of Science ®Google Scholar
• Brouillard, F., and C. E. Cremisi. 2003. Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells. J. Biol. Chem. 278:39509–39516.
   PubMedGoogle Scholar
• Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
   PubMed Web of Science ®Google Scholar
• Brzozowski, A. M., A. C. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G. L. Greene, J. A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753–758.
   PubMed Web of Science ®Google Scholar
• Cavailles, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741–3751.
   PubMed Web of Science ®Google Scholar
• Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383:99–103.
   PubMed Web of Science ®Google Scholar
• Chevillard-Briet, M., D. Trouche, and L. Vandel. 2002. Control of CBP co-activating activity by arginine methylation. EMBO J. 21:5457–5466.
   PubMed Web of Science ®Google Scholar
• Coqueret, O., and H. Gascan. 2000. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275:18794–18800.
   PubMedGoogle Scholar
• Coradini, D., A. Biffi, C. Pellizzaro, E. Pirronello, and G. Di Fronzo. 1997. Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines. Tumour Biol. 18:22–29.
   PubMedGoogle Scholar
• D'Amico, M., K. Wu, M. Fu, M. Rao, C. Albanese, R. G. Russell, H. Lian, D. Bregman, M. A. White, and R. G. Pestell. 2004. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res. 64:4122–4130.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., P. P. Hu, T. F. Kowalik, J. Yingling, and X. F. Wang. 1997. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17:2030–2037.
   PubMedGoogle Scholar
• Delaunay, F., K. Pettersson, M. Tujague, and J. A. Gustafsson. 2000. Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol. Pharmacol. 58:584–590.
   PubMedGoogle Scholar
• Delavaine, L., and N. B. La Thangue. 1999. Control of E2F activity by p21Waf1/Cip1. Oncogene 18:5381–5392.
   PubMed Web of Science ®Google Scholar
• Feigelson, H. S., and B. E. Henderson. 1996. Estrogens and breast cancer. Carcinogenesis 17:2279–2284.
   PubMed Web of Science ®Google Scholar
• Feng, X. H., E. H. Filvaroff, and R. Derynck. 1995. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 270:24237–24245.
   PubMed Web of Science ®Google Scholar
• Graham, J. D., and C. L. Clarke. 1997. Physiological action of progesterone in target tissues. Endocr. Rev. 18:502–519.
   PubMed Web of Science ®Google Scholar
• Greenspan, P., E. P. Mayer, and S. D. Fowler. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100:965–973.
   PubMed Web of Science ®Google Scholar
• Groshong, S. D., G. I. Owen, B. Grimison, I. E. Schauer, M. C. Todd, T. A. Langan, R. A. Sclafani, C. A. Lange, and K. B. Horwitz. 1997. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol. Endocrinol. 11:1593–1607.
   PubMed Web of Science ®Google Scholar
• Hahm, H. A., M. M. Ip, K. Darcy, J. D. Black, W. K. Shea, S. Forczek, M. Yoshimura, and T. Oka. 1990. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. II. Functional differentiation under serum-free conditions. In Vitro Cell. Dev. Biol. 26:803–814.
   PubMedGoogle Scholar
• Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018–1021.
   PubMed Web of Science ®Google Scholar
• Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and M. Brown. 1996. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93:11540–11555.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56–64.
   PubMed Web of Science ®Google Scholar
• Harris, T. E., J. H. Albrecht, M. Nakanishi, and G. J. Darlington. 2001. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J. Biol. Chem. 276:29200–29209.
   PubMed Web of Science ®Google Scholar
• Inadera, H. 2003. Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway. Biochem. Biophys. Res. Commun. 309:272–278.
   PubMedGoogle Scholar
• Inadera, H., S. Hashimoto, H. Y. Dong, T. Suzuki, S. Nagai, T. Yamashita, N. Toyoda, and K. Matsushima. 2000. WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 275:108–114.
   PubMed Web of Science ®Google Scholar
• Jacq, X., C. Brou, Y. Lutz, I. Davidson, P. Chambon, and L. Tora. 1994. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107–117.
   PubMedGoogle Scholar
• Jung, D. J., S. K. Lee, and J. W. Lee. 2001. Agonist-dependent repression mediated by mutant estrogen receptor alpha that lacks the activation function 2 core domain. J. Biol. Chem. 276:37280–37283.
   PubMedGoogle Scholar
• Kawasaki, H., R. Eckner, T. P. Yao, K. Taira, R. Chiu, D. M. Livingston, and K. K. Yokoyama. 1998. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393:284–289.
   PubMed Web of Science ®Google Scholar
• Kitaura, H., M. Shinshi, Y. Uchikoshi, T. Ono, S. M. Iguchi-Ariga, and H. Ariga. 2000. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J. Biol. Chem. 275:10477–10483.
   PubMedGoogle Scholar
• Korach, K. S. 1994. Insights from the study of animals lacking functional estrogen receptor. Science 266:1524–1527.
   PubMedGoogle Scholar
• Kraus, W. L., and J. T. Kadonaga. 1998. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12:331–342.
   PubMed Web of Science ®Google Scholar
• Kumar, R., R. A. Wang, A. Mazumdar, A. H. Talukder, M. Mandal, Z. Yang, R. Bagheri-Yarmand, A. Sahin, G. Hortobagyi, L. Adam, C. J. Barnes, and R. K. Vadlamudi. 2002. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 418:654–657.
   PubMedGoogle Scholar
• Liu, M., M. H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:142–153.
   PubMed Web of Science ®Google Scholar
• Lonard, D. M., Z. Nawaz, C. L. Smith, and B. W. O'Malley. 2000. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell 5:939–948.
   PubMed Web of Science ®Google Scholar
• Mal, A., D. Chattopadhyay, M. K. Ghosh, R. Y. Poon, T. Hunter, and M. L. Harter. 2000. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. J. Cell Biol. 149:281–292.
   PubMedGoogle Scholar
• Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835–839.
   PubMed Web of Science ®Google Scholar
• Marmorstein, R. 2001. Protein modules that manipulate histone tails for chromatin regulation. Nat. Rev. Mol. Cell Biol. 2:422–432.
   PubMed Web of Science ®Google Scholar
• Merot, Y., R. Metivier, G. Penot, D. Manu, C. Saligaut, F. Gannon, F. Pakdel, O. Kah, and G. Flouriot. 2004. The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell. J. Biol. Chem. 279:26184–26191.
   PubMedGoogle Scholar
• Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, D. M. Livingston, and G. P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451–5455.
   PubMed Web of Science ®Google Scholar
• Nakanishi, M., G. R. Adami, R. S. Robetorye, A. Noda, S. F. Venable, D. Dimitrov, O. M. Pereira-Smith, and J. R. Smith. 1995. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 92:4352–4356.
   PubMedGoogle Scholar
• Nilsson, S., and J. A. Gustafsson. 2000. Estrogen receptor transcription and transactivation: basic aspects of estrogen action. Breast Cancer Res. 2:360–366.
   PubMedGoogle Scholar
• Nilsson, S., S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J. A. Gustafsson. 2001. Mechanisms of estrogen action. Physiol. Rev. 81:1535–1565.
   PubMed Web of Science ®Google Scholar
• Oh, Y. L., J. S. Choi, S. Y. Song, Y. H. Ko, B. K. Han, S. J. Nam, and J. H. Yang. 2001. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status. Pathol. Int. 51:94–99.
   PubMed Web of Science ®Google Scholar
• Owen, G. I., J. K. Richer, L. Tung, G. Takimoto, and K. B. Horwitz. 1998. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273:10696–10701.
   PubMed Web of Science ®Google Scholar
• Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523–527.
   PubMed Web of Science ®Google Scholar
• Petz, L. N., and A. M. Nardulli. 2000. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol. Endocrinol. 14:972–985.
   PubMedGoogle Scholar
• Petz, L. N., Y. S. Ziegler, M. A. Loven, and A. M. Nardulli. 2002. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 143:4583–4591.
   PubMed Web of Science ®Google Scholar
• Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
   PubMed Web of Science ®Google Scholar
• Planas-Silva, M. D., and R. A. Weinberg. 1997. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol. 17:4059–4069.
   PubMed Web of Science ®Google Scholar
• Polesskaya, A., I. Naguibneva, L. Fritsch, A. Duquet, S. Ait-Si-Ali, P. Robin, A. Vervisch, L. L. Pritchard, P. Cole, and A. Harel-Bellan. 2001. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20:6816–6825.
   PubMed Web of Science ®Google Scholar
• Prall, O. W., B. Sarcevic, E. A. Musgrove, C. K. Watts, and R. L. Sutherland. 1997. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272:10882–10894.
   PubMed Web of Science ®Google Scholar
• Redeuilh, G., A. Attia, J. Mester, and M. Sabbah. 2002. Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases. Oncogene 21:5773–5782.
   PubMedGoogle Scholar
• Reid, G., M. R. Hubner, R. Metivier, H. Brand, S. Denger, D. Manu, J. Beaudouin, J. Ellenberg, and F. Gannon. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11:695–707.
   PubMed Web of Science ®Google Scholar
• Richer, J. K., B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz. 2002. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:5209–5218.
   PubMed Web of Science ®Google Scholar
• Rosenfeld, M. G., and C. K. Glass. 2001. Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 276:36865–36868.
   PubMed Web of Science ®Google Scholar
• Sabbah, M., D. Courilleau, J. Mester, and G. Redeuilh. 1999. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA 96:11217–11222.
   PubMed Web of Science ®Google Scholar
• Sabbah, M., F. Gouilleux, B. Sola, G. Redeuilh, and E. E. Baulieu. 1991. Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element. Proc. Natl. Acad. Sci. USA 88:390–394.
   PubMed Web of Science ®Google Scholar
• Sabbah, M., K. I. Kang, L. Tora, and G. Redeuilh. 1998. Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB. Biochem. J. 336:639–646.
   PubMedGoogle Scholar
• Schultz, J. R., L. N. Petz, and A. M. Nardulli. 2003. Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression. Mol. Cell. Endocrinol. 201:165–175.
   PubMed Web of Science ®Google Scholar
• Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843–852.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Shi, Y., M. Downes, W. Xie, H. Y. Kao, P. Ordentlich, C. C. Tsai, M. Hon, and R. M. Evans. 2001. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev. 15:1140–1151.
   PubMed Web of Science ®Google Scholar
• Sutherland, R. L., R. E. Hall, and I. W. Taylor. 1983. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res. 43:3998–4006.
   PubMed Web of Science ®Google Scholar
• Thompson, E. W., S. Paik, N. Brunner, C. L. Sommers, G. Zugmaier, R. Clarke, T. B. Shima, J. Torri, S. Donahue, and M. E. Lippman. 1992. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol. 150:534–544.
   PubMed Web of Science ®Google Scholar
• Toscani, A., D. R. Soprano, and K. J. Soprano. 1990. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J. Biol. Chem. 265:5722–5730.
   PubMed Web of Science ®Google Scholar
• van den Hoff, M. J., A. F. Moorman, and W. H. Lamers. 1992. Electroporation in ‘intracellular’ buffer increases cell survival. Nucleic Acids Res. 20:2902.
   PubMed Web of Science ®Google Scholar
• Visvader, J. E., and G. J. Lindeman. 2003. Transcriptional regulators in mammary gland development and cancer. Int. J. Biochem. Cell Biol. 35:1034–1051.
   PubMed Web of Science ®Google Scholar
• Wakasugi, E., T. Kobayashi, Y. Tamaki, Y. Ito, I. Miyashiro, Y. Komoike, T. Takeda, E. Shin, Y. Takatsuka, N. Kikkawa, T. Monden, and M. Monden. 1997. p21(Waf1/Cip1) and p53 protein expression in breast cancer. Am. J. Clin. Pathol. 107:684–691.
   PubMedGoogle Scholar
• Wakeling, A. E., M. Dukes, and J. Bowler. 1991. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:3867–3873.
   PubMed Web of Science ®Google Scholar
• Wu, S. Y., M. C. Thomas, S. Y. Hou, V. Likhite, and C. M. Chiang. 1999. Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription. J. Biol. Chem. 274:23480–23490.
   PubMedGoogle Scholar
• Yahata, T., W. Shao, H. Endoh, J. Hur, K. R. Coser, H. Sun, Y. Ueda, S. Kato, K. J. Isselbacher, M. Brown, and T. Shioda. 2001. Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev. 15:2598–2612.
   PubMedGoogle Scholar
• Zhang, R., L. Averboukh, W. Zhu, H. Zhang, H. Jo, P. J. Dempsey, R. J. Coffey, A. B. Pardee, and P. Liang. 1998. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol. Cell. Biol. 18:6131–6141.
   PubMed Web of Science ®Google Scholar
• Zwijsen, R. M., R. Klompmaker, E. B. Wientjens, P. M. Kristel, B. van der Burg, and R. J. Michalides. 1996. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16:2554–2560.
   PubMed Web of Science ®Google Scholar